# Drug-Drug Interaction Study: ASP2151 and Montelukast

> **NCT02321748** · PHASE1 · COMPLETED · sponsor: **Maruho Europe Limited** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Montelukast
- **DRUG:** ASP2151

## Key facts

- **NCT ID:** NCT02321748
- **Lead sponsor:** Maruho Europe Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02321748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02321748, "Drug-Drug Interaction Study: ASP2151 and Montelukast". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02321748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*